Deoxybrevianamide E

• UNSPSC Description:

  Deoxybrevianamide E, an indole alkaloid, is a biosynthetic precursor for advanced metabolites isolated from the marine-derived Aspergillus sp.[1].

• Target Antigen:

  Endogenous Metabolite

• Type:

  Natural Products

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/deoxybrevianamide-e.html

• Purity:

  99.2

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(N[C@H](C1=O)CC2=C(NC3=C2C=CC=C3)C(C)(C=C)C)[C@]4(N1CCC4)[H]

• Molecular Weight:

  351.44

• References & Citations:

  [1]Hikaru Kato, et al. Study on the biosynthesis of the notoamides: Pinacol-type rearrangement of the isoprenyl unit in deoxybrevianamide E and 6-hydroxydeoxybrevianamide E. Tetrahedron Lett. 2011 Dec 21;52(51):6923-6926.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C, 3 years (Powder)

• Clinical Information:

  No Development Reported

• CAS Number:

  34610-68-9